Skip to main content

Lakeside Holding Ltd

For the period ended Dec 31, 2024. Filed Feb 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2024 · Filed Feb 14, 2025

QNME$0.34+5.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unaudited Condensed Consolidated Statements of Cash Flows

CONDENSSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Six Months Ended December 31,
20242023
Cash flows from operating activities:
Net loss$(3,282,227)$(243,061)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation – G&A50,80435,991
Depreciation – cost of revenue36,32836,328
Amortization and interest expense of operating lease assets989,003439,142
Depreciation of right-of-use finance assets15,48014,385
Provision of allowance for expected credit loss1,95649,591
Deferred tax expense89,58126,125
Loss from derecognition of shares in subsidiary—73,151
Changes in operating assets and liabilities:
Accounts receivable – third parties424,648(479,056)
Accounts receivable – related parties565,766(192,609)
Contract assets98,118(27,169)
Inventories, net(10,328)—
Due from related parties(241,702)40,740
Prepayment, other deposit(112,620)(23,269)
Accounts payables – third parties28,285539,542
Accounts payables – related parties(156,165)241,721
Accrued expense and other payables312,722122,547
Operating lease liabilities(742,649)(396,263)
Net cash (used in) provided by operating activities(1,933,000)257,836
Cash flows from investing activities:
Purchase of furniture and equipment(36,072)—
Payment for leasehold improvement(75,008)—
Net cash payment for asset acquisition(552,721)—
Loan to a third party(686,697)—
Payment made for investment in other entity—(29,906)
Net cash outflow from deconsolidation of a subsidiary (Appendix A)—(48,893)
Net cash used in investing activities(1,350,498)(78,799)
Cash flows from financing activities:
Proceeds from loans195,000225,000
Repayment of loans(339,914)(185,856)
Repayment of equipment and vehicle loans(55,877)(59,708)
Principal payment of finance lease liabilities(14,964)(13,429)
Payment for deferring offering cost—(140,000)
Advances from Hupan Pharmaceutical prior to acquisition276,365
Proceeds from initial public offering, net of share issuance costs5,351,281—
Advanced to related parties(311,185)—
Proceeds from shareholders—158,455
Repayment to shareholders(805,345)—
Net cash provided by (used in) financing activities4,295,361(15,538)
Effect of exchange rate changes on cash(11,999)3,216
Net increase in cash999,864166,715
Cash, beginning of the period123,550174,018
Cash, end of the period$1,123,414$340,733
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for income tax$—$—
Cash paid for interest$45,953$15,503
SUPPLEMENTAL SCHEDULE OF NON-CASH IN INVESTING AND FINANCING ACTIVITIES
Deferred offering costs within due to shareholders$—$500,826
Deferred offering costs within accrued expense and other payables$—$241,176
Additions to property and equipment included in loan payable$102,235—
Additions to leasehold improvement and furniture and fixture through account payable$42,803$—
Settlement of due to shareholder and advance to related party$311,185$—
NON-CASH ACTIVITIES
Right of use assets obtained in exchange for operating lease obligations$1,445,498$—
Right of use assets obtained in exchange for finance lease obligation$89,003$19,982
APPENDIX A – Net cash outflow from deconsolidation of a subsidiary
Working capital, net$29,812
Investment in other entity recognized(15,741)
Elimination of NCl at deconsolidation of a subsidiary10,187
Loss from deconsolidation of a subsidiary(73,151)
Cash$(48,893)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.